Nitrofurantoin Glenmark Pharmaceuticals Europe

Active Ingredient:: Nitrofurantoin
Origin:: EU

Nitrofurantoin Glenmark Pharmaceuticals Europe (Nitrofurantoin)

Q: What is Nitrofurantoin Glenmark Pharmaceuticals Europe used for?

Nitrofurantoin Glenmark Pharmaceuticals Europe is an oral nitrofuran antibiotic indicated for the treatment of uncomplicated urinary tract infections, including acute cystitis, and for prophylaxis of recurrent infections in adults.

Q: How does nitrofurantoin work to treat infections?

Nitrofurantoin is reduced by bacterial enzymes to reactive metabolites that damage bacterial DNA, ribosomal proteins and carbohydrate‑metabolising enzymes, resulting in rapid bactericidal activity against susceptible urinary pathogens.

Q: What is the usual dose of Nitrofurantoin Glenmark?

The dosage of Nitrofurantoin Glenmark is determined by the prescribing clinician based on the patient’s condition, renal function and local treatment guidelines. Patients should follow the prescriber’s instructions precisely.

Q: Is Nitrofurantoin safe to use during pregnancy or breastfeeding?

Nitrofurantoin is classified as pregnancy category B, indicating no evidence of risk in animal studies and limited human data. It is generally considered safe in early and mid‑pregnancy but is avoided in the late third trimester. Breastfeeding mothers should monitor the infant for gastrointestinal upset.

Q: How do I order Nitrofurantoin Glenmark from GNH India?

To request Nitrofurantoin Glenmark, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Q: How does Nitrofurantoin compare with other urinary anti‑infectives?

Compared with other oral agents such as trimethoprim‑sulfamethoxazole or fluoroquinolones, nitrofurantoin offers a narrow spectrum focused on common uropathogens, a low propensity for resistance development, and limited systemic exposure, making it a preferred first‑line option for uncomplicated cystitis in many guidelines.

Q: What are the recommended storage conditions for Nitrofurantoin Glenmark?

Nitrofurantoin Glenmark tablets should be stored below 25 °C in their original container, protected from moisture and direct sunlight. Do not store in a bathroom or near heat sources to maintain product stability.

Q: How is Nitrofurantoin Glenmark administered?

The medication is taken orally, usually with a full glass of water. It may be taken with food or on an empty stomach, depending on the prescriber’s advice, to improve tolerability and absorption.

Q: What are the most serious risks associated with Nitrofurantoin?

Serious adverse events include pulmonary toxicity (interstitial pneumonitis or fibrosis), severe hepatic injury, hemolytic anemia in patients with G6PD deficiency, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Prompt medical attention is required if any of these occur.

Q: Who should not use Nitrofurantoin Glenmark?

Nitrofurantoin is contraindicated in patients with severe renal impairment (creatinine clearance <60 mL/min), known hypersensitivity to nitrofurantoin, G6PD deficiency, and in late third‑trimester pregnancy. Clinicians should also exercise caution in patients with a history of pulmonary disease.

Nitrofurantoin, the active ingredient in Nitrofurantoin Glenmark Pharmaceuticals Europe, is a nitrofuran antibiotic presented as an oral tablet for oral use. It treats uncomplicated urinary tract infections in adult patients.
GNH India supplies Nitrofurantoin Glenmark Pharmaceuticals Europe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Glenmark Pharmaceuticals Europe Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nitrofurantoin is a nitrofuran antibiotic used to manage infections of the urinary tract.

Uncomplicated urinary tract infection: eradicates susceptible uropathogens and resolves symptoms.
Acute cystitis: provides bactericidal activity to clear infection of the bladder.
Prophylaxis of recurrent urinary tract infection: reduces the frequency of future infections when taken regularly.

How It Works

Nitrofurantoin is reduced by bacterial flavoproteins to reactive intermediates that damage bacterial DNA, ribosomal proteins and enzymes involved in carbohydrate metabolism. This multi‑target inhibition leads to rapid bactericidal activity against susceptible urinary pathogens while sparing most host cells.

Side Effects

Nitrofurantoin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

Nausea: mild to moderate stomach upset.
Loss of appetite: reduced desire to eat.
Headache: transient cranial discomfort.
Diarrhoea: loose stools, usually self‑limiting.
Metallic taste: transient alteration of taste perception.
Mild skin rash: limited erythema or itching.

Serious or Rare Side Effects

Pulmonary toxicity: interstitial pneumonitis or fibrosis, requiring immediate medical attention.
Hepatic injury: elevated liver enzymes or hepatitis.
Severe allergic reaction: anaphylaxis with rash, swelling, and airway compromise.
Hemolytic anemia in G6PD deficiency: rapid drop in red blood cells.
Peripheral neuropathy: numbness or tingling in extremities.
Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin detachment.

Precautions & Warnings

Before prescribing Nitrofurantoin, clinicians should consider several safety factors.

Renal function assessment: avoid use when creatinine clearance is <60 mL/min.
Pregnancy safety: category B, generally acceptable but avoid in late third trimester.
Breastfeeding: monitor infant for gastrointestinal upset.
G6PD deficiency: contraindicated due to risk of hemolysis.
Monitor for pulmonary symptoms: discontinue if cough or dyspnoea develop.
Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Nitrofurantoin can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid)

Antacids containing magnesium or aluminium: markedly reduce absorption.
Probenecid: decreases renal excretion, increasing plasma levels.

Moderate Interactions (Monitor Closely)

Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
Diuretics: can affect renal clearance, necessitating dose adjustment.
NSAIDs: combined use may impair renal function, especially in susceptible patients.

Frequently Asked Questions

Nitrofurantoin Glenmark Pharmaceuticals Europe is an oral nitrofuran antibiotic indicated for the treatment of uncomplicated urinary tract infections, including acute cystitis, and for prophylaxis of recurrent infections in adults.

Nitrofurantoin is reduced by bacterial enzymes to reactive metabolites that damage bacterial DNA, ribosomal proteins and carbohydrate‑metabolising enzymes, resulting in rapid bactericidal activity against susceptible urinary pathogens.

The dosage of Nitrofurantoin Glenmark is determined by the prescribing clinician based on the patient’s condition, renal function and local treatment guidelines. Patients should follow the prescriber’s instructions precisely.

Nitrofurantoin is classified as pregnancy category B, indicating no evidence of risk in animal studies and limited human data. It is generally considered safe in early and mid‑pregnancy but is avoided in the late third trimester. Breastfeeding mothers should monitor the infant for gastrointestinal upset.

To request Nitrofurantoin Glenmark, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with other oral agents such as trimethoprim‑sulfamethoxazole or fluoroquinolones, nitrofurantoin offers a narrow spectrum focused on common uropathogens, a low propensity for resistance development, and limited systemic exposure, making it a preferred first‑line option for uncomplicated cystitis in many guidelines.

Nitrofurantoin Glenmark tablets should be stored below 25 °C in their original container, protected from moisture and direct sunlight. Do not store in a bathroom or near heat sources to maintain product stability.

The medication is taken orally, usually with a full glass of water. It may be taken with food or on an empty stomach, depending on the prescriber’s advice, to improve tolerability and absorption.

Serious adverse events include pulmonary toxicity (interstitial pneumonitis or fibrosis), severe hepatic injury, hemolytic anemia in patients with G6PD deficiency, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Prompt medical attention is required if any of these occur.

Nitrofurantoin is contraindicated in patients with severe renal impairment (creatinine clearance <60 mL/min), known hypersensitivity to nitrofurantoin, G6PD deficiency, and in late third‑trimester pregnancy. Clinicians should also exercise caution in patients with a history of pulmonary disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 27 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.